How our vaccines team supports innovation across global healthcare systems
Better late than never? What developers of SARS-CoV-2 vaccines in early-to -late-stage development should consider
Unfortunately, as of today the ongoing pandemic is still far from being under control, with close to 3...
The regulatory environment for the development of mRNA vaccines during COVID-19
A growing interest in mRNA-based technologies over the last decades has allowed the rapid development and deployment of...
Vaccine Development in Paediatric Populations – How to Proceed for SARS-CoV-2 Vaccines?
While adult clinical trials of SARS-CoV-2 vaccines have rapidly moved into Phase 3, no clinical trials have been...
How far are we with the accelerated development of SARS-CoV-2 vaccines – a review and outlook
Development of SARS-CoV-2 vaccine comes with an unprecedented number of challenges ranging from CMC to clinical development. This...
Accelerated development and licensure of Coronavirus vaccines
The newly emerging 2019 novel Coronavirus is threatening the world as it spreads with a so far unprecedented...